Heritage Foundation: Puberty Blockers, Cross-Sex Hormones, and Youth Suicide
SUMMARYLowering legal barriers to make it easier for minors to undergo cross-sex medical interventions without parental consent does not reduce suicide rates—in fact, it likely leads to higher rates of suicide among young people in states that adopt these changes. States should instead adopt parental bills of rights that affirm the fact that parents have primary responsibility for their children’s education and health, and that require school officials and health professionals to receive permission from parents before administering health services, including medication and “gender-affirming” counseling, to children under 18. States should also tighten the criteria for receiving cross-sex treatments, including raising the minimum eligibility age.
U.S. policymakers are seeking to make it easier for minors to access puberty blockers and cross-sex hormones based on the claim that doing so reduces suicide risk.
Studies finding that “gender-affirming” interventions prevent suicide fail to show a causal relationship and have been poorly executed.
A superior research design shows that easing access to puberty blockers and cross-sex hormones by minors without parental consent increases suicide rates.
Dr. Greene presents a careful, well developed argument well worth your attention.